Solventum Co. (NYSE:SOLV) Given Average Rating of “Hold” by Analysts

Solventum Co. (NYSE:SOLV) has received a consensus rating of “Hold” from the eleven ratings firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $68.29.

SOLV has been the subject of a number of research analyst reports. Mizuho began coverage on shares of Solventum in a report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price objective for the company. Morgan Stanley lifted their price target on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. Finally, Piper Sandler increased their price objective on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th.

Solventum Stock Up 1.2 %

NYSE:SOLV opened at $74.29 on Tuesday. Solventum has a twelve month low of $47.16 and a twelve month high of $96.05. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The stock has a fifty day simple moving average of $70.40 and a 200-day simple moving average of $68.09.

Institutional Trading of Solventum

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Copeland Capital Management LLC bought a new position in shares of Solventum in the 3rd quarter worth $26,000. Modus Advisors LLC bought a new position in Solventum in the fourth quarter worth about $25,000. Mather Group LLC. purchased a new stake in shares of Solventum during the third quarter valued at about $27,000. Stonebridge Financial Group LLC bought a new stake in shares of Solventum in the 4th quarter valued at about $26,000. Finally, True Wealth Design LLC grew its position in shares of Solventum by 23,550.0% in the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after buying an additional 471 shares during the last quarter.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.